BioVie Inc.
Treatment of Ascites
Last updated:
Abstract:
A method for treating ascites patients by administering the peptide drug terlipressin by continuous infusion. The patients include those whose ascites condition has not progressed to hepatorenal syndrome (HRS). Administration may be accomplished with a continuous infusion pump.
Status:
Application
Type:
Utility
Filling date:
9 Apr 2019
Issue date:
5 Dec 2019